Browsing by Author Darbà, Josep

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 61  next >
Issue DateTitleAuthor(s)
Sep-2016A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regionsDarbà, Josep; Ramírez, Gabriela; García-Rivero, Juan L.; Mayoralas, Sagrario; Pascual, José Francisco; Roger, Albert; Vargas, Diego; Bijedic, Adi
Jan-2021A discrete choice experiment to understand preferences of patients with type 2 diabetes treated with injectable non-insulinic agentsDarbà, Josep; Ascanio, Meritxell
Apr-2019Admissions and Cost of Hospitalisation of Phenylketonuria: Spanish Claims Database AnalysisDarbà, Josep; Ascanio, Meritxell
26-May-2022Ambulatory and hospital care of glaucoma in Spain and associated medical costsDarbà, Josep; Marsà, Alícia
4-May-2021Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018)Darbà, Josep; Marsà, Alícia
13-Feb-2020Analysis of the management and costs of headache disorders in Spain during the period 2011-2016: a retrospective multicentre observational studyDarbà, Josep; Marsà, Alícia
Jul-2021Atopic dermatitis in specialized centers in Spain: a retrospective analysis of incidence and costs (2000-2017)Darbà, Josep; Marsà, Alícia
Sep-2018Budget impact analysis of oral Fisiogen Ferro Forte versus intravenous iron for the management of iron deficiency in chronic kidney disease in SpainDarbà, Josep; Ascanio, Meritxell
Jan-2021Burden of Hodgkin and non-Hodgkin lymphoma in Spain over a 10-year period: productivity losses due to premature mortalityDarbà, Josep; Marsà, Alícia
1-Oct-2022Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital careDarbà, Josep; Marsà, Alícia
Oct-2019Characteristics, comorbidities, and use of healthcare resources of patients with phenylketonuria: a population-based studyDarbà, Josep
5-Feb-2020Characteristics, management and medical costs of patients with depressive disorders admitted in primary and specialised care centres in Spain between 2011 and 2016Darbà, Josep; Marsà, Alícia
28-Oct-2021Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costsDarbà, Josep; Marsà, Alícia
Dec-2020Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011-2017)Darbà, Josep; Marsà, Alícia
Feb-2019Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalinSicras Mainar, Antoni; Rejas, Javier; Pérez-Paramo, Maria; Sánchez-Álvarez, Luis; Navarro-Artieda, Ruth; Darbà, Josep
Nov-2017Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspectiveMezquita-Raya, Pedro; Darbà, Josep; Ascanio, Meritxell; Ramírez de Arellano, Antonio
20-Dec-2019Cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes in Portugal: evidence from SWITCH 1&2 trialsDarbà, Josep; Ascanio, Meritxell; Carvalho, Davide; Conde, Vasco; Pedersen, Kasper S.
Feb-2015Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in SpainDarbà, Josep; Kaskens, Lisette; Sorio Vilela, Francesc; Lothgren, Mickael
11-Oct-2019Current status and direct medical cost of amyotrophic lateral sclerosis in the region of Catalonia: A population-based analysisDarbà, Josep
Apr-2020Current status and use of resources of Lysosomal Storage Diseases: Analysis of a Spanish claims databaseDarbà, Josep; Marsà, Alícia